Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Els Verhoeyen

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2015
A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation StatusFloriane Fusil, Sara Calattini, Fouzia Amirache, et al.
Human Gene Therapy|April 3, 2012
Stem cell factor-displaying simian immunodeficiency viral vectors together with a low conditioning regimen allow for long-term engraftment of gene-marked autologous hematopoietic stem cells in macaquesEls Verhoeyen, Francis Relouzat, Marie Cambot, et al.
Blood Advances|November 20, 2020
Combining T-cell-specific activation and in vivo gene delivery through CD3-targeted lentiviral vectorsAnnika M Frank, Angela H Braun, Lea Scheib, et al.
Clinical & Translational Immunology|May 6, 2024
Optimisation of a primary human CAR-NK cell manufacturing pipelineAline Pfefferle, Julian Contet, Kahlia Wong, et al.
Human Gene Therapy|January 11, 2021
Safe and Effective <i>In Vivo</i> Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating DevelopmentPaula Cannon, Aravind Asokan, Agnieszka Czechowicz, et al.
Oncoimmunology|September 1, 2022
IRE1α overexpression in malignant cells limits tumor progression by inducing an anti-cancer immune responseAdriana Martinez-Turtos, Rachel Paul, Manuel Grima-Reyes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2006
Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactionsJudit Szécsi, Rosybel Drury, Véronique Josserand, et al.
Plos One|January 10, 2013
Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodiesPatrycja J Lech, Gregory J Tobin, Ruth Bushnell, et al.
EMBO Molecular Medicine|September 19, 2018
Anett Pfeiffer, Frederic B Thalheimer, Sylvia Hartmann, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 10, 2025
An Isogenic Human Myoblast Cell Model for Cystinosis Myopathy Reveals Alteration of Key Myogenic Regulatory ProteinsLouise Medaer, Roger Mora, Zhuoheng Zhou, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2015
A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation StatusFloriane Fusil, Sara Calattini, Fouzia Amirache, et al.
Human Gene Therapy|April 3, 2012
Stem cell factor-displaying simian immunodeficiency viral vectors together with a low conditioning regimen allow for long-term engraftment of gene-marked autologous hematopoietic stem cells in macaquesEls Verhoeyen, Francis Relouzat, Marie Cambot, et al.
Blood Advances|November 20, 2020
Combining T-cell-specific activation and in vivo gene delivery through CD3-targeted lentiviral vectorsAnnika M Frank, Angela H Braun, Lea Scheib, et al.
Clinical & Translational Immunology|May 6, 2024
Optimisation of a primary human CAR-NK cell manufacturing pipelineAline Pfefferle, Julian Contet, Kahlia Wong, et al.
Human Gene Therapy|January 11, 2021
Safe and Effective <i>In Vivo</i> Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating DevelopmentPaula Cannon, Aravind Asokan, Agnieszka Czechowicz, et al.
Oncoimmunology|September 1, 2022
IRE1α overexpression in malignant cells limits tumor progression by inducing an anti-cancer immune responseAdriana Martinez-Turtos, Rachel Paul, Manuel Grima-Reyes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2006
Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactionsJudit Szécsi, Rosybel Drury, Véronique Josserand, et al.
Plos One|January 10, 2013
Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodiesPatrycja J Lech, Gregory J Tobin, Ruth Bushnell, et al.
EMBO Molecular Medicine|September 19, 2018
Anett Pfeiffer, Frederic B Thalheimer, Sylvia Hartmann, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 10, 2025
An Isogenic Human Myoblast Cell Model for Cystinosis Myopathy Reveals Alteration of Key Myogenic Regulatory ProteinsLouise Medaer, Roger Mora, Zhuoheng Zhou, et al.
Pageof 12